Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain.

Nativi C, Gualdani R, Dragoni E, Di Cesare Mannelli L, Sostegni S, Norcini M, Gabrielli G, la Marca G, Richichi B, Francesconi O, Moncelli MR, Ghelardini C, Roelens S.

Sci Rep. 2013;3:2005. doi: 10.1038/srep02005.

2.

Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels.

Huang Q, Chen Y, Gong N, Wang YX.

Metabolism. 2016 Apr;65(4):463-74. doi: 10.1016/j.metabol.2015.12.002. Epub 2015 Dec 17.

PMID:
26975538
3.

(+)-Borneol attenuates oxaliplatin-induced neuropathic hyperalgesia in mice.

Zhou HH, Zhang L, Zhou QG, Fang Y, Ge WH.

Neuroreport. 2016 Feb 10;27(3):160-5. doi: 10.1097/WNR.0000000000000516.

PMID:
26730517
4.

Glial role in oxaliplatin-induced neuropathic pain.

Di Cesare Mannelli L, Pacini A, Micheli L, Tani A, Zanardelli M, Ghelardini C.

Exp Neurol. 2014 Nov;261:22-33. doi: 10.1016/j.expneurol.2014.06.016. Epub 2014 Jun 23.

PMID:
24967684
5.

Gosha-jinki-gan reduced oxaliplatin-induced hypersensitivity to cold sensation and its effect would be related to suppression of the expression of TRPM8 and TRPA1 in rats.

Kato Y, Tateai Y, Ohkubo M, Saito Y, Amagai SY, Kimura YS, Iimura N, Okada M, Matsumoto A, Mano Y, Hirosawa I, Ohuchi K, Tajima M, Asahi M, Kotaki H, Yamada H.

Anticancer Drugs. 2014 Jan;25(1):39-43. doi: 10.1097/CAD.0000000000000022.

PMID:
24052105
6.

Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation.

Nassini R, Gees M, Harrison S, De Siena G, Materazzi S, Moretto N, Failli P, Preti D, Marchetti N, Cavazzini A, Mancini F, Pedretti P, Nilius B, Patacchini R, Geppetti P.

Pain. 2011 Jul;152(7):1621-31. doi: 10.1016/j.pain.2011.02.051. Epub 2011 Apr 9.

PMID:
21481532
7.

Effect of synthetic eel calcitonin, elcatonin, on cold and mechanical allodynia induced by oxaliplatin and paclitaxel in rats.

Aoki M, Mori A, Nakahara T, Sakamoto K, Ishii K.

Eur J Pharmacol. 2012 Dec 5;696(1-3):62-9. doi: 10.1016/j.ejphar.2012.09.007. Epub 2012 Sep 19.

PMID:
23001015
8.

Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats.

Mori T, Kanbara T, Harumiya M, Iwase Y, Masumoto A, Komiya S, Nakamura A, Shibasaki M, Kanemasa T, Sakaguchi G, Suzuki T.

J Pharmacol Sci. 2014;126(1):47-55. Epub 2014 Aug 20.

9.

Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion.

Jiang SP, Zhang ZD, Kang LM, Wang QH, Zhang L, Chen HP.

Exp Neurol. 2016 Jan;275 Pt 1:11-6. doi: 10.1016/j.expneurol.2015.11.001. Epub 2015 Nov 9.

PMID:
26546510
10.

[Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].

Taguchi K.

Yakugaku Zasshi. 2016;136(2):287-96. doi: 10.1248/yakushi.15-00214. Review. Japanese.

11.

Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.

Xiao WH, Bennett GJ.

Pain. 2012 Mar;153(3):704-9. doi: 10.1016/j.pain.2011.12.011. Epub 2012 Jan 13.

12.

Spinal transient receptor potential ankyrin 1 channel induces mechanical hypersensitivity, increases cutaneous blood flow, and mediates the pronociceptive action of dynorphin A.

Wei H, Saarnilehto M, Falck L, Viisanen H, Lasierra M, Koivisto A, Pertovaara A.

J Physiol Pharmacol. 2013 Jun;64(3):331-40.

13.

7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.

Baraldi PG, Romagnoli R, Saponaro G, Aghazadeh Tabrizi M, Baraldi S, Pedretti P, Fusi C, Nassini R, Materazzi S, Geppetti P, Preti D.

Bioorg Med Chem. 2012 Mar 1;20(5):1690-8. doi: 10.1016/j.bmc.2012.01.020. Epub 2012 Jan 24.

PMID:
22325155
14.

Lipoyl-Homotaurine Derivative (ADM_12) Reverts Oxaliplatin-induced Neuropathy and Reduces Cancer Cells Malignancy by Inhibiting Carbonic Anhydrase IX (CAIX).

Fragai M, Comito G, Di Cesare Mannelli L, Gualdani R, Calderone V, Louka A, Richichi B, Francesconi O, Angeli A, Nocentini A, Gratteri P, Chiarugi P, Ghelardini C, Tadini-Buoninsegni F, Supuran CT, Nativi C.

J Med Chem. 2017 Oct 19. doi: 10.1021/acs.jmedchem.7b01237. [Epub ahead of print]

PMID:
29048889
15.

Cerebrospinal Fluid Oxaliplatin Contributes to the Acute Pain Induced by Systemic Administration of Oxaliplatin.

Huang ZZ, Li D, Ou-Yang HD, Liu CC, Liu XG, Ma C, Wei JY, Liu Y, Xin WJ.

Anesthesiology. 2016 May;124(5):1109-21. doi: 10.1097/ALN.0000000000001084.

PMID:
26978408
16.

Oxaliplatin-induced painful neuropathy--flicker of hope or hopeless pain?

Stengel M, Baron R.

Pain. 2009 Aug;144(3):225-6. doi: 10.1016/j.pain.2009.05.004. Epub 2009 May 23. No abstract available.

PMID:
19477073
17.

Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats.

Aoki M, Kurauchi Y, Mori A, Nakahara T, Sakamoto K, Ishii K.

Biol Pharm Bull. 2014;37(2):322-6.

18.

Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy.

Koivisto A, Hukkanen M, Saarnilehto M, Chapman H, Kuokkanen K, Wei H, Viisanen H, Akerman KE, Lindstedt K, Pertovaara A.

Pharmacol Res. 2012 Jan;65(1):149-58. doi: 10.1016/j.phrs.2011.10.006. Epub 2011 Nov 23.

PMID:
22133672
19.

Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic pain.

Kanat O, Bagdas D, Ozboluk HY, Gurun MS.

J BUON. 2013 Oct-Dec;18(4):1012-8. Erratum in: J BUON. 2014 Jan-Mar;19(1):323. Kanat, D [corrected to Kanat, O].

PMID:
24344031
20.

TRPA1 antagonists as potential analgesic drugs.

Andrade EL, Meotti FC, Calixto JB.

Pharmacol Ther. 2012 Feb;133(2):189-204. doi: 10.1016/j.pharmthera.2011.10.008. Epub 2011 Nov 15. Review.

PMID:
22119554

Supplemental Content

Support Center